ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NNBR vs TMO // GROSS PROFIT MARGIN

NN Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NNBR 1 — TMO 10
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NNBR VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NNBR TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -8.50% 9.30% -17.80 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield -1.95% 2.40% -4.35 TMO /fcf-yield <GO>
Operating Margin -4.50% 17.40% -21.90 TMO /operating-margins <GO>
Net Profit Margin 8.10% 15.10% -7.00 TMO /net-margins <GO>
Revenue Growth (YoY) -9.10% 3.90% -13.00 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.61 4.50 -3.89 TMO /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.2 62.9 -5.66 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 10.1x 36.3x -26.20 NNBR /forward-pe <GO>
Enterprise Scale & Market Cap $371.2M $262.22B -$261.85B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NNBR REV TMO REV NNBR GROSS % TMO GROSS % NNBR FCF TMO FCF
FY 2025 $422.2M $44.56B — — -$7.2M $6.29B
FY 2024 $464.3M $42.88B — — -$7.2M $7.27B
FY 2023 $489.3M $42.86B — — $29.3M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NNBR // BETA —
TMO // BETA 0.94